Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-235

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 51655-235). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 235 52)

Label for Rosuvastatin Tablets USP 20 mg, film-coated oral tablets. The bottle contains 30 tablets. Label includes dosage storage instructions, manufacturer Northwind Pharmaceuticals, and packaging by Northwind Health Company, LLC. NDC 51655-235-52.*

FDA Label Image

Figure (Rosuvastatin Fig1)

A box plot graph comparing the percent change from baseline in LDL-C levels across different doses (10, 20, 40, and 80 mg) of four statin drugs: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The y-axis shows percent change, ranging from 0 to -75%, indicating effectiveness in lowering LDL-C.*

FDA Label Image

Figure (Rosuvastatin Fig2)

A Kaplan-Meier cumulative incidence curve comparing Rosuvastatin Calcium (Rosuva) and placebo over approximately five years. The y-axis shows cumulative incidence in percentage, and the x-axis shows time in years. The graph includes hazard ratio (HR 0.56) with 95% confidence interval and P-value (<0.001). Number at risk is displayed below the x-axis for both Rosuvastatin and placebo groups at multiple time points.*

FDA Label Image

Figure (Rosuvastatin Fig3)

A data table summarizing clinical event outcomes comparing Rosuvastatin Calcium 20 mg to placebo, including event counts, hazard ratios with 95% confidence intervals, and p-values for endpoints such as primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. The table includes a forest plot visualizing hazard ratios with confidence intervals for each endpoint.*

FDA Label Image

Chemical Structure (Rosuvastatin Str)

Chemical structure of Rosuvastatin Calcium, illustrating its molecular framework including fluorophenyl and sulfonamide groups, as well as calcium ions (Ca2+) associated with the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.